IL162864A - Formulation for inhalation having a poured bulk density of from 0.28 to 0.38g/ml, comprising formoterol
- Google Patents
Formulation for inhalation having a poured bulk density of from 0.28 to 0.38g/ml, comprising formoterol
Info
Publication number
IL162864A
IL162864AIL16286498AIL16286498AIL162864AIL 162864 AIL162864 AIL 162864AIL 16286498 AIL16286498 AIL 16286498AIL 16286498 AIL16286498 AIL 16286498AIL 162864 AIL162864 AIL 162864A
Authority
IL
Israel
Prior art keywords
formoterol
inhalation
formulation
bulk density
poured bulk
Prior art date
Application number
IL16286498A
Inventor
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9700134Aexternal-prioritypatent/SE9700134D0/en
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of IL162864ApublicationCriticalpatent/IL162864A/en
Budesonide/formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof
New formulation for inhalation having a poured bulnew formulation for inhalation having a poured bulk density of from 0,28 to 0,38 g/ml, comprising fok density of from 0,28 to 0,38 g/ml, comprising formoterol rmoterol
New formulation for inhalation having a poured bulk density of from 0,28 to 0,38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments.